Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
05 01 2023
Historique:
received: 02 04 2022
revised: 26 07 2022
accepted: 18 08 2022
pubmed: 14 9 2022
medline: 11 1 2023
entrez: 13 9 2022
Statut: ppublish

Résumé

In multiple sclerosis, spontaneous remyelination is generally incomplete and heterogeneous across patients. A high heterogeneity in remyelination may also exist across lesions within the same individual, suggesting the presence of local factors interfering with myelin regeneration. In this study we explored in vivo the regional distribution of myelin repair and investigated its relationship with neurodegeneration. We first took advantage of the myelin binding property of the amyloid radiotracer 11C-PiB to conduct a longitudinal 11C-PiB PET study in an original cohort of 19 participants with a relapsing-remitting form of multiple sclerosis, followed-up over a period of 1-4 months. We then replicated our results on an independent cohort of 40 people with multiple sclerosis followed-up over 1 year with magnetization transfer imaging, an MRI metrics sensitive to myelin content. For each imaging method, voxel-wise maps of myelin content changes were generated according to modality-specific thresholds. We demonstrated a selective failure of remyelination in periventricular white matter lesions of people with multiple sclerosis in both cohorts. In both the original and the replication cohort, we estimated that the probability of demyelinated voxels to remyelinate over the follow-up increased significantly as a function of the distance from ventricular CSF. Enlarged choroid plexus, a recently discovered biomarker linked to neuroinflammation, was found to be associated with the periventricular failure of remyelination in the two cohorts (r = -0.79, P = 0.0018; r = -0.40, P = 0.045, respectively), suggesting a role of the brain-CSF barrier in affecting myelin repair in surrounding tissues. In both cohorts, the failure of remyelination in periventricular white matter lesions was associated with lower thalamic volume (r = 0.86, P < 0.0001; r = 0.33; P = 0.069, respectively), an imaging marker of neurodegeneration. Interestingly, we also showed an association between the periventricular failure of remyelination and regional cortical atrophy that was mediated by the number of cortex-derived tracts passing through periventricular white matter lesions, especially in patients at the relapsing-remitting stage. Our findings demonstrate that lesion proximity to ventricles is associated with a failure of myelin repair and support the hypothesis that a selective periventricular remyelination failure in combination with the large number of tracts connecting periventricular lesions with cortical areas is a key mechanism contributing to cortical damage in multiple sclerosis.

Identifiants

pubmed: 36097347
pii: 6696508
doi: 10.1093/brain/awac334
doi:

Substances chimiques

2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 0
Thiazoles 0
Aniline Compounds 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

182-194

Subventions

Organisme : European Leukodystrophy Association
ID : 2007-0481
Organisme : INSERM-DHOS
Organisme : Programme Hospitalier de Recherche Clinique
Organisme : Agence nationale de la Recherche
ID : MNP2008-007125
Organisme : Fondation pour la recherche médicale
Organisme : Commissariat aux energies atomique
Organisme : ARSEP
Organisme : ECTRIMS
Organisme : Assistance Publique des Hôpitaux de Paris
Organisme : Investissements d'avenir
ID : ANR-10-IAIHU-06

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Matteo Tonietto (M)

Paris Brain Institute, Sorbonne Université, ICM, CNRS, Inserm, Paris, France.
Service Hospitalier Frédéric Joliot, Université Paris-Saclay, CEA, CNRS, Inserm, BioMaps, Orsay, France.

Emilie Poirion (E)

Paris Brain Institute, Sorbonne Université, ICM, CNRS, Inserm, Paris, France.

Andrea Lazzarotto (A)

Paris Brain Institute, Sorbonne Université, ICM, CNRS, Inserm, Paris, France.
Neurology Department, St Antoine Hospital, APHP, Paris, France.

Vito Ricigliano (V)

Paris Brain Institute, Sorbonne Université, ICM, CNRS, Inserm, Paris, France.
Neurology Department, St Antoine Hospital, APHP, Paris, France.

Caroline Papeix (C)

Paris Brain Institute, Sorbonne Université, ICM, CNRS, Inserm, Paris, France.
Neurology Department, Pitié-Salpêtrière Hospital, APHP, Paris, France.

Michel Bottlaender (M)

Service Hospitalier Frédéric Joliot, Université Paris-Saclay, CEA, CNRS, Inserm, BioMaps, Orsay, France.

Benedetta Bodini (B)

Paris Brain Institute, Sorbonne Université, ICM, CNRS, Inserm, Paris, France.
Neurology Department, St Antoine Hospital, APHP, Paris, France.

Bruno Stankoff (B)

Paris Brain Institute, Sorbonne Université, ICM, CNRS, Inserm, Paris, France.
Neurology Department, St Antoine Hospital, APHP, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH